Plasma Amyloid-beta Levels are Significantly Associated with a Transition Toward Alzheimer's Disease as Measured by Cognitive Decline and Change in Neocortical Amyloid Burden
Alan Rembach, Andrew D Watt, William J Wilson, Victor L Villemagne, Samantha C Burnham, Kathryn A Ellis, Paul Maruff, David Ames, Christopher C Rowe, S Lance Macaulay, Ashley I Bush, Ralph N Martins, Colin L Masters, James D Doecke
Journal of Alzheimer's Disease | IOS PRESS | Published : 2014
Related Projects (1)
This research was also supported by the Science Industry and Endowment Fund (http://www.sief.org.au/), and the National Health and Medical Research Council (NHMRC) via the Dementia Collaborative Research Centres program (DCRC2) and the Commonwealth Scientific and Industrial Research Organisation (CSIRO) (http://www.aibl.csiro.au/). MHRI acknowledges the funding support from the Victorian Government's Operational Infrastructure Support program. Pfizer International has contributed financial support to assist with analysis of blood samples and to further the AIBL research program. The McCusker Foundation has contributed financial and in-kind support to AIBL.